![Christopher Landeg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Landeg
Chief Operating Officer at Quotient Sciences (Reading) Ltd.
Christopher Landeg active positions
Companies | Position | Start | End |
---|---|---|---|
Quotient Sciences (Reading) Ltd.
![]() Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Director/Board Member | - | - |
Chief Operating Officer | - | - |
Career history of Christopher Landeg
Statistics
International
United Kingdom | 2 |
Operational
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Quotient Sciences (Reading) Ltd.
![]() Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Christopher Landeg
- Experience